StonvexLoading…
StonvexCore line items from MAT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $862.17M | $5.35B | $3.58B | $1.85B |
Operating Income | $-102.68M | $546.42M | $405.37M | $25.52M |
Net Income | $61.03M | $397.58M | $291.39M | $53.35M |
EPS (Diluted) | $0.20 | $1.24 | $0.90 | $0.04 |
Total Assets | $6.33B | $6.64B | $6.59B | $6.25B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $866.00M | $1.24B | $691.89M | $870.45M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 300.97M | 321.79M | 325.13M | 328.50M |